At a glance
ClinicalIndex Comparison RecordN/ACompleted· 193 enrolled
Drug / intervention
Flulaval +4 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Immune Response Induced by Different Manufacturers of Influenza Vaccines
In Brief
A clinical study evaluating Flulaval, Fluvirin, and 3 other interventions for Immune Response. Completed, enrolled 193 participants across 1 site.
Detailed Summary
The goal of this research is to find out how the body's immune system responds to different manufacturer's "flu" vaccines.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsImmune Response
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2008
First PostedMay 2009
Primary CompletionApr 2016
TodayJul 2026
First PostedMay 15, 2009
Enrollment StartOct 1, 2008
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7.5 yearsPosted 17.1 years ago
Interventions
Flulavalbiological
one 0.5-mL dose via intramuscular injection
Fluvirinbiological
one 0.5-mL dose via intramuscular injection
Fluzonebiological
one 0.5-mL dose via intramuscular injection
Fluarixbiological
one 0.5-mL dose via intramuscular injection
Afluriabiological
one 0.5-mL dose via intramuscular injection